Korro Bio, Inc.

Korro Bio, Inc.

KRRO·NASDAQ

$11.08

+2.1%
HealthcareBiotechnology

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

At a Glance

Live Snapshot
Market Cap$110.28M
EPS-12.4800
P/E Ratio-0.89
Earnings Date08/11/2026

krro

Additional Paid-In Capital

Last Annual Value

435.06M

3-Year CAGR

437%

5-Year CAGR

9%

10-Year CAGR

%

Korro Bio, Inc.

Korro Bio, Inc. Competitors Analysis of Additional Paid-In Capital

KRRO · NASDAQ
CompanyAdditional Paid-In Capital
CAGR 3Y
CAGR 5Y
CAGR 10Y
KRRO logo
Korro Bio, Inc.
NASDAQ:KRRO
435.06M
7.2%6.9%N/A 
352.75M
303.4%272.3%N/A
0.00
N/AN/AN/A
512.78M
23.8%23.2%N/A
ALT logo
Altimmune, Inc.
NASDAQ:ALT
879.29M
9.7%12.1%28.6%
593.41M
479.2%N/AN/A
918.19M
6.2%4.3%N/A
804.39M
8.4%11.3%N/A
1.72B
5.8%12.7%18.6%
430.67M
305.2%N/AN/A
ANNX logo
Annexon, Inc.
NASDAQ:ANNX
1.13B
11.1%16.4%N/A
Korro Bio, Inc.

Korro Bio, Inc. Fair Value Envelope

KRRO · NASDAQ

Our analysis suggests that KRRO has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $11.08, this represents a potential HIDDEN relative to our calculated worth for Korro Bio, Inc..

Intrinsic Value
Current Price: $11.08